A randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation

AIM: To evaluate the efficacy and safety of tegaserod, 6 mg twice daily (b.i.d.), in men and women with chronic constipation (CC) from China. METHODS: This was a multicenter, double-blind, placebo-controlled study. Following a 2-wk treatment-free baseline period, patients were randomized to receive...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lin, San-Ren, Ke, Mei-Yun, Luo, Jin-Yan, Yuan, Yao-Zong, Wang, Ji-Yao, diTommaso, Shelley, Walter, Verena, Huang, Jiaqing
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Co., Limited 2007
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4066006/
https://ncbi.nlm.nih.gov/pubmed/17278196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v13.i5.732
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados